Ibutamoren (MK-677): Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides โ
๐TL;DR
- โข4 community protocols documented
- โขEvidence level: Structured Community Data
- โขBased on 300 community reports
- โข3 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Oral Convenience | Clinical trials used oral MK-677 at 25 mg daily, with studies ranging from weeks to 2 years. The oral route is the intended administration method as MK-677 is a non-peptide small molecule. | Community universally uses oral administration, making MK-677 uniquely accessible among GH secretagogues (no injection required). This convenience is a major driver of its popularity. | low MK-677 is one of the few GH secretagogues that is orally bioavailable as it is a non-peptide small molecule, not an actual peptide. Community and clinical administration routes are aligned. |
| Heart Failure Concerns | A clinical trial in elderly patients with hip fractures showed increased heart failure incidence in the MK-677 group, leading to early trial termination. Development was subsequently discontinued. | Community awareness of the heart failure risk is inconsistent. Some users are aware and consider it relevant only to elderly/frail populations. Others are unaware of this safety signal entirely. | high The heart failure signal in elderly patients is a significant safety concern that is underrepresented in community discussions. Water retention may contribute to cardiac strain in susceptible individuals. |
| Duration of Use | Clinical trials ran from 2 weeks to 2 years. The longest study (2-year, elderly) maintained IGF-1 elevation but did not show significant body composition improvements vs placebo. | Community use ranges from 8-week cycles to continuous use for months or years. Many users are unaware of the 2-year study showing maintained GH/IGF-1 elevation without corresponding body composition benefits. | high The 2-year clinical trial finding of maintained GH/IGF-1 elevation without body composition benefits challenges the rationale for long-term community use. |
| Blood Sugar and Insulin | Clinical studies demonstrated increased fasting glucose and insulin resistance with MK-677 use. Some studies showed impaired glucose tolerance. | Community is generally aware of blood sugar effects. Some users monitor fasting glucose and HbA1c during use. Others combine MK-677 with metformin or berberine to manage insulin sensitivity. | high Insulin resistance and elevated blood glucose are well-documented effects that the community manages through monitoring and concurrent supplementation, but this represents off-label risk mitigation. |
Compare these community approaches with published research findings.
Community Protocols
Standard Oral Protocol
Popular- Route
- Oral
- Dose
- 25 mg
- Frequency
- Once daily
- Duration
- 8-16 weeks
Most commonly reported dose; taken orally as capsule or liquid, typically in the morning or before bed
Beginner/Low-Dose Protocol
Popular- Route
- Oral
- Dose
- 10-15 mg
- Frequency
- Once daily
- Duration
- 8-12 weeks
Starting dose to assess tolerance; allows evaluation of appetite and water retention side effects before increasing
Sleep-Optimized Protocol
Common- Route
- Oral
- Dose
- 12.5-25 mg
- Frequency
- Once daily before bed
- Duration
- 8-16 weeks
Pre-bed dosing to leverage nocturnal GH pulse and minimize daytime appetite effects
Extended Low-Dose Protocol
Common- Route
- Oral
- Dose
- 10-12.5 mg
- Frequency
- Once daily
- Duration
- 3-6 months
Lower dose for extended use; some users run continuously for 6+ months for anti-aging benefits
Stacking Patterns
MK-677 + SARMs
PopularPopular in the bodybuilding community; MK-677 for GH elevation combined with SARMs for direct anabolic effects. Common SARMs include LGD-4033 and RAD-140.
MK-677 + Testosterone
CommonOral GH secretagogue convenience combined with testosterone replacement for comprehensive hormonal optimization
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 300+ self-experimenters report. Free with email.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Sources
- Reddit r/Peptides|MK-677 experience reports and side effect discussions(accessed 2026-02-16)
- Reddit r/sarmssourcetalk|MK-677 source quality and experience threads(accessed 2026-02-16)
- Swolverine|MK-677 for Beginners (growth, recovery, sleep guide)(accessed 2026-02-16)
- Peptides.org|MK-677 Dosage Calculator and Chart(accessed 2026-02-16)
- Wellness Pulse|Doctors Warn Against MK-677 Contradicting Fitness Industry Opinions(accessed 2026-02-16)
- Wikipedia|Ibutamoren pharmacology and clinical trial overview(accessed 2026-02-16)
- Healthy Male (Australia)|What You Need to Know About MK-677 (medical perspective)(accessed 2026-02-16)
Community Evidence Overview#
This page presents aggregated community protocols and anecdotal reports for Ibutamoren (MK-677). The information below is gathered from peptide research forums, Reddit communities, and self-experimenter reports. This is not clinical evidence and should not be used as medical guidance.
MK-677 is one of the most popular GH secretagogues in the community, primarily due to its oral bioavailability (no injections required). Despite being technically a non-peptide small molecule, it is universally discussed alongside peptide GH secretagogues due to its ghrelin receptor agonist mechanism. It has substantial clinical trial data, though development was discontinued.
Understanding Protocol Divergence#
Convenience-Driven Popularity#
MK-677's popularity is largely driven by oral convenience rather than superior efficacy. The ability to take a daily capsule rather than multiple daily injections makes it the entry point for many users interested in GH optimization. However, this convenience comes with significant side effects (appetite increase, water retention, insulin resistance) that injectable secretagogues like ipamorelin largely avoid.
Underappreciated Safety Signals#
Two significant clinical findings are often underrepresented in community discussions. First, a clinical trial in elderly patients showed increased heart failure, leading to study termination. Second, a 2-year study showed maintained GH/IGF-1 elevation without corresponding body composition benefits in elderly subjects, questioning the rationale for extended use.
Blood Sugar Management#
MK-677's effect on fasting glucose and insulin sensitivity is well-documented clinically and recognized by the community. Many users monitor blood glucose and some concurrently use metformin or berberine. This self-directed metabolic management represents a significant departure from clinical practice.
Commonly Reported Outcomes#
Community members frequently report the following when using MK-677:
- Increased appetite: The most consistently reported effect, often intense in the first 2-4 weeks
- Improved sleep: Deeper, more restful sleep, typically noticed within the first week
- Water retention: Bloating and fluid retention, especially at 25 mg doses
- Muscle fullness: Enhanced muscle pumps and fullness during training
- Fatigue/lethargy: Some users report daytime tiredness, especially when dosing in the morning
- Numbness/tingling: Transient tingling in extremities, considered a sign of GH elevation
Important Caveats#
- MK-677 was discontinued from clinical development due to safety concerns
- Heart failure risk in susceptible populations is a documented clinical finding
- Blood sugar elevation and insulin resistance are well-documented effects
- 2-year clinical data questions the body composition benefits of extended use
- Not FDA-approved for any medical use
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Frequently Asked Questions About Ibutamoren (MK-677)
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.